Insider · CIK 0001293973
Christopher B Ehrlich
Files at CERO (CERO THERAPEUTICS HOLDINGS, INC.). First filing -, latest -.
Christopher B Ehrlich files SEC Form 4 as CEO, chair and director at CERO (CERO THERAPEUTICS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher B Ehrlich has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +4,530,997 | $0.00 | $0 | 4,530,997 | Jan 9, 2026 |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +61,843 | $0.00 | $0 | 61,842 | Jun 2, 2025 |
| Mar 4, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +119,486 | $0.00 | $0 | 119,486 | Mar 6, 2025 |
| Feb 24, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,275,000 | $0.00 | $0 | 2,550,000 | Feb 26, 2025 |
| Dec 2, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,275,000 | $0.00 | $0 | 1,275,000 | Dec 4, 2024 |
Questions about Christopher B Ehrlich
Answered from the filings on this page, as of the latest one.
Is Christopher B Ehrlich buying or selling?
Christopher B Ehrlich has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher B Ehrlich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher B Ehrlich has 0.
Where does Christopher B Ehrlich file Form 4?
Christopher B Ehrlich has filed Form 4 at CERO (CERO THERAPEUTICS HOLDINGS, INC.) as Chairman and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.